Current market catalysts

8-K filing — GENERAL ELECTRIC CO (GE)

Filed: 2026-09-08 AccNo: 0000950142-26-002501 Size: 2 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

IonQ Says Research Paper Estimates 20,000-Physical-Qubit Quantum Computer Could Break Bitcoin's secp256k1 Elliptic Curve In Just Under 26 Days; Says On Track For Fault-Tolerant 10,000-Qubit System In 2027

Clearmind Medicine Says Yale University’s IRB Approves Initiation Of Patient Recruitment For Parts B And C Of Phase I/II Clinical Trial Evaluating CMND‑100

Clearmind Medicine Inc. (NASDAQ:CMND) (the "Company" or "Clearmind"), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogen for scalable treatment of

enGene Holdings Q3 EPS $(0.47) Misses $(0.43) Estimate

enGene Holdings (NASDAQ:ENGN) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.43) by 9.3 percent. This is a 17.54 percent increase over losses of $(0.57) per share from

8-K filing — GROUP 1 AUTOMOTIVE INC (GPI)

Filed: 2026-09-08 AccNo: 0001193125-26-384390 Size: 398 KB Item 2.02: Results of Operations and Financial Condition Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

8-K filing — IonQ, Inc. (IONQ-WT)

Filed: 2026-09-08 AccNo: 0001193125-26-384388 Size: 228 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

IonQ Raises FY2026 Sales Guidance from $280.000M-$290.000M to $450.000M-$460.000M

IonQ (NYSE:IONQ) raises FY2026 sales outlook from $280.000 million-$290.000 million to $450.000 million-$460.000 million. This outlook includes the contributions of SkyWater Technology beginning on July 31, 2026, the

8-K filing — Pyxis Oncology, Inc. (PYXS)

Filed: 2026-09-08 AccNo: 0001193125-26-384386 Size: 266 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

D-Wave Secures up to $100 Million in US Funding

D-Wave Quantum Inc. (NASDAQ: QBTS) stock rebounds after finalizing $100M U.S. deal for next-gen quantum systems.

YYForce Announces Incorporation Of 70-30 Joint Venture Facadevision AI With Integral Cleaning For Drone, AI-Enabled Facade Inspection In Singapore; Expects Commercial Deployment To Begin Q3 2026

BioVie Announces Bezisterim Has Potential To Treat Parkinson's Disease; To Hold Talks With FDA Over Phase 3 Trial Design

BioVie Inc. (NASDAQ: BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced next stage of

8-K filing — NABORS INDUSTRIES LTD (NBR)

Filed: 2026-09-08 AccNo: 0001104659-26-105673 Size: 2 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — Philip Morris International Inc. (PM)

Filed: 2026-09-08 AccNo: 0001628280-26-060806 Size: 833 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Quantum Cyber Announces Acquisition Of Lambda Hyperplane 8-A100 AI Compute Cluster With Eight NVIDIA A100 GPUs For Swarm Operating System, Quantum Station; To Be Installed At Bridgeport, Connecticut Facility

Quantinuum Finalized $100M CHIPS Funding From U.S. Department Of Commerce

Quantinuum (Nasdaq: QNT), a leading quantum computing company, today announced it has finalized an agreement with the U.S. Department of Commerce's CHIPS Research and Development Office for $100 million in federal

Memorial Sloan Kettering Cancer Center Joins BriaCell’s Ongoing Pivotal Phase 3 Study Of Bria-IMT Plus Immune Checkpoint Inhibitor In Metastatic Breast Cancer

Now Enrolling Patients at Memorial Sloan Kettering Cancer Center (MSK)BriaCell Phase 3 trial featured in Nature Medicine as "Eleven clinical trials that will shape medicine in 2026" PHILADELPHIA and VANCOUVER,

Seabridge Gold Announces Energization Of Treaty Creek Terminal Supporting KSM Project On August 27; Expects Facility Ready For Service By November 2026

GE Aerospace Inks $11.75B Deal To Acquire Consolidated Precision Products

GE Aerospace (NYSE:GE) announced today that it has signed an agreement to acquire Consolidated Precision Products (CPP), a leading manufacturer of highly engineered castings, from private investment firms Warburg Pincus

Medicus Pharma Says CD228V ADC Now Principal Strategic Priority, With Initial Development In Relapsed Or Refractory Melanoma; Says FDA Authorized Initiation Of Registrational Phase 2b SkinJect Study In Gorlin Syndrome

Verastem Oncology To Host Investor Event On October 14 To Present Initial Efficacy And Updated Data For VS-7375 In Pancreatic, Lung, And Colorectal Cancers From Ongoing TARGET-D Clinical Development Program

Investor event and webcast to be held Wednesday, October 14, 2026, at 8:00 am ETVerastem Oncology (NASDAQ:VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven

8-K filing — enGene Therapeutics Inc. (ENGNW)

Filed: 2026-09-08 AccNo: 0001193125-26-384380 Size: 419 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

Artiva Biotherapeutics Says It Is Initiating Phase 3 Trial Of AlloNK Plus Rituximab In About 150 Refractory RA Patients In H2 2026; Expects Updated Phase 2a Data From At Least 20 RA Patients In H2 2026

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Analyst ratings and news for high-yield healthcare stocks Medtronic (3.06%), Smith & Nephew (2.74%) and GSK (3.65%).

Pyxis Oncology Appoint Thomas Civik Chairman, CEO, Effective Sept. 4

Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, announced today that its Board of Directors has appointed Thomas Civik as Chief

V2X Awarded $19M IDIQ Contract By U.S. Marine Corps To Deliver Tempest Counter-Unmanned Aerial System Vehicles

V2X, Inc. (NYSE:VVX) today announced it has been awarded a $19 million indefinite-delivery/indefinite-quantity contract by the U.S. Marine Corps to deliver Tempest counter-Unmanned Aerial System (C-UAS) vehicles,

Novartis shares are trading lower after the company announced the pelacarsen phase III Lp(a)HORIZON trial did not meet its primary endpoint. The global Phase III HARBOR study evaluating del-desiran in people living with myotonic dystrophy type 1 did not meet its primary endpoint.

Six Flags Entertainment Acquires ArieForce One; Financial Terms Undisclosed

Six Flags Entertainment Corporation (NYSE:FUN), North America's largest regional amusement-resort operator, has acquired ArieForce One, the celebrated steel roller coaster that captured the imagination of

8-K filing — UNITED COMMUNITY BANKS INC (UCB)

Filed: 2026-09-08 AccNo: 0001104659-26-105666 Size: 4 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — Soluna Holdings, Inc (SLNHP)

Filed: 2026-09-08 AccNo: 0001493152-26-041699 Size: 278 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Franklin Templeton’s Clarion Partners To Acquire Majority Stake In Stoneshield Capital, Tripling European AUM To $13B And Boosting Alternatives Platform Beyond $300B

Franklin Templeton, Inc. ("Franklin Templeton") (NYSE:BEN), through its leading real estate subsidiary Clarion Partners, LLC, ("Clarion"), is pleased to announce that it has entered into a definitive